- Home
- FATE vs MUX Comparison
FATE vs MUX Comparison
Compare FATE & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- MUX
- Stock Information
- Founded
- FATE 2007
- MUX 1979
- Country
- FATE United States
- MUX Canada
- Employees
- FATE N/A
- MUX N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- MUX Precious Metals
- Sector
- FATE Health Care
- MUX Basic Materials
- Exchange
- FATE Nasdaq
- MUX Nasdaq
- Market Cap
- FATE 406.5M
- MUX 411.8M
- IPO Year
- FATE 2013
- MUX N/A
- Fundamental
- Price
- FATE $1.27
- MUX $8.38
- Analyst Decision
- FATE Hold
- MUX Strong Buy
- Analyst Count
- FATE 10
- MUX 2
- Target Price
- FATE $6.75
- MUX $15.63
- AVG Volume (30 Days)
- FATE 3.2M
- MUX 409.3K
- Earning Date
- FATE 02-24-2025
- MUX 02-28-2025
- Dividend Yield
- FATE N/A
- MUX N/A
- EPS Growth
- FATE N/A
- MUX N/A
- EPS
- FATE N/A
- MUX 2.07
- Revenue
- FATE $13,447,000.00
- MUX $199,634,000.00
- Revenue This Year
- FATE N/A
- MUX $22.76
- Revenue Next Year
- FATE N/A
- MUX $18.67
- P/E Ratio
- FATE N/A
- MUX $4.06
- Revenue Growth
- FATE N/A
- MUX 47.02
- 52 Week Low
- FATE $1.04
- MUX $5.92
- 52 Week High
- FATE $8.83
- MUX $12.50
- Technical
- Relative Strength Index (RSI)
- FATE 31.94
- MUX 51.89
- Support Level
- FATE $1.22
- MUX $7.92
- Resistance Level
- FATE $1.36
- MUX $8.60
- Average True Range (ATR)
- FATE 0.15
- MUX 0.32
- MACD
- FATE -0.02
- MUX 0.06
- Stochastic Oscillator
- FATE 24.21
- MUX 79.44
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company focused on precious and base minerals in Argentina, Mexico, and the United States. The company's overall revenue is principally derived from the production of gold and silver. The company owns and operates the wholly-owned El Gallo 1 mine in Mexico, and has a minority shareholding in the company that operates the San Jose mine in Argentina. More than half the company's gold output is produced by the El Gallo 1 mine. The remaining gold production, and the majority of silver production, is produced by the San Jose mine. Geographically, the majority is from Canada.